Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Accounts Receivable are created when a customer has received a product but has not yet paid for that product. PT Siloam International Hospitals Tbk's accounts receivables for the quarter that ended in Mar. 2026 was €86.8 Mil.
Accounts receivable can be measured by Days Sales Outstanding.
PT Siloam International Hospitals Tbk's Days Sales Outstanding for the quarter that ended in Mar. 2026 was 47.29.
In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. PT Siloam International Hospitals Tbk's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was €-0.01.
PT Siloam International Hospitals Tbk Accounts Receivable Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.
PT Siloam International Hospitals Tbk's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:
2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), PT Siloam International Hospitals Tbk's accounts receivable are only considered to be worth 75% of book value:
PT Siloam International Hospitals Tbk's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.
If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.
Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.
PT Siloam International Hospitals Tbk Accounts Receivable Related Terms
PT Siloam International Hospitals Tbk Accounts Receivable Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Siloam International Hospitals Tbk Accounts Receivable Chart
What does a Accounts Receivable of €86.8 Mil mean?
PT Siloam International Hospitals Tbk (FRA:2LS) has a Accounts Receivable of €86.8 Mil as of Mar. 2026. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on PT Siloam International Hospitals Tbk and its competitors.
Is PT Siloam International Hospitals Tbk's Accounts Receivable too high?
PT Siloam International Hospitals Tbk's current Accounts Receivable is €86.8 Mil. Overall, PT Siloam International Hospitals Tbk has a GF Score™ of 90/100, reflecting its overall financial health beyond just this single metric.
How does PT Siloam International Hospitals Tbk's Accounts Receivable compare to HCA and THC?
PT Siloam International Hospitals Tbk's Accounts Receivable of €86.8 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Receivable for a Healthcare Providers & Services company?
A good Accounts Receivable depends on the Healthcare Providers & Services industry context. However, Accounts Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Receivable mean?
A high Accounts Receivable can signal that a stock is expensive relative to its fundamentals. Accounts receivable is the amount a company expects to receive from credit-extending customers. View historical data on PT Siloam International Hospitals Tbk and its competitors. PT Siloam International Hospitals Tbk's current Accounts Receivable is €86.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Siloam International Hospitals Tbk stock overvalued right now?
PT Siloam International Hospitals Tbk (FRA:2LS) has a current Accounts Receivable of €86.8 Mil. The stock's GF Value™ is €0.12, compared to a current price of €0.09 — trading 22.1% below its estimated fair value. The current Accounts Receivable is €86.8 Mil. PT Siloam International Hospitals Tbk's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Receivable calculated?
Accounts Receivable is calculated from a company's financial statements. For PT Siloam International Hospitals Tbk (FRA:2LS), the current Accounts Receivable is €86.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Siloam International Hospitals Tbk (FRA:2LS) Overvalued in 2026?
Based on GuruFocus' analysis, PT Siloam International Hospitals Tbk stock appears to be undervalued.
The current stock price of €0.09 is trading 22.1% below its estimated GF Value™ of €0.12.
Key valuation signals for FRA:2LS:
Accounts Receivable: €86.8 Mil
GF Value™: €0.12 vs. price of €0.09 (22.1% below fair value)
No single metric tells the full story. See the FRA:2LS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Siloam International Hospitals Tbk Business Description
PT Siloam International Hospitals Tbk operates a network of hospitals in Indonesia. Its hospitals are located in the Greater Jakarta area and across Java, Sumatra, Kalimantan, Sulawesi, Bali, Nusa Tenggara, Ambon, and other areas across Indonesia, along with several Siloam Clinics. The company offers an integrated, one-stop care ecosystem designed to provide comprehensive healthcare services, spanning examination, diagnosis, clinical management, rehabilitation, and health education. Additionally, it offers special clinical services in the following segments, including neurosciences, neurology, digestive, cardiac, orthopedic, etc., by running the Center of Excellence and specialty centers. The company generates the majority of its revenue by offering hospitalization and outpatient services.
90GF Score
Get the complete analysis for FRA:2LS
Accounts Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:2LS has been successfully added to your 
